Trial Profile
Study of comparison of ustekinumab between anti-tumor necrosis factor-alpha drug-naive and anti-tumor necrosis factor-alpha drug-resistant Japanese psoriasis cases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 29 Jul 2016 New trial record